Wockhardt Limited (BOM:532300)
India · Delayed Price · Currency is INR 1,912.70
+27.95 (1.48%)
At close: Oct 28, 2026
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 310.91 billion as of October 28, 2026. Its market cap has increased by 47.82% in one year.
Market Cap
310.91B
Enterprise Value
330.51B
Revenue
36.53B
Global Rank
n/a
Country Rank
n/a
PE Ratio
75.94
ChartMarket Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 310.91B, an increase of 1,686.47%. That is a compound annual growth rate of 11.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 310.91B | 32.31% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 601.41B |
| Ipca Laboratories | 491.83B |
| Gland Pharma | 469.15B |
| Ajanta Pharma | 422.41B |
| Emcure Pharmaceuticals | 337.67B |
| Wockhardt | 294.05B |
| Piramal Pharma | 259.43B |
| Cohance Lifesciences | 177.35B |